A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
Abstract Background Dysthyroid optic neuropathy (DON) is a serious threatening vision loss in Graves’ ophthalmopathy (GO). Although the European Group on Graves’ Ophthalmopathy (EUGOGO) recommend intravenous methylprednisolone therapy for first line treatment, some characteristics predicting the res...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2023-01-01
|
| Seri Bilgileri: | BMC Ophthalmology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12886-023-02789-5 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|